$2.46
0.010.41%
Last update: Nov 10, 5:10 PM
Boundless Bio Inc
BOLDNASDAQ
Boundless Bio rose 95.2% from $1.26 to $2.46, ahead of the S&P 500's +11.2%. Its worst day was Dec 3 (−7.7%), and its low came Feb 4 at $1.05.
Nov 11, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Boundless Bio closed at its lowest level of the year, 16.7% below where the year started.
−3.7% · S&P 500 −0.5%
EPS of $-0.58 missed the $-0.49 estimate on $0.00 revenue.
+0.9% · S&P 500 +0.9%
Story events cover the past 12 months · Times ET
Boundless Bio shares rose 30.0%, while the S&P 500 rose 1.2%.
+30.0% · S&P 500 +1.2%
EPS of $-0.60 missed the $-0.55 estimate on $0.00 revenue.
−5.9% · S&P 500 +0.8%
Boundless Bio shares rose 85.7%, while the S&P 500 fell 1.5%.
+85.7%, the year's best day, on 66M shares, the year's heaviest volume · S&P 500 −1.5%
EPS of $-1.06 missed the $-0.57 estimate on $0.00 revenue.
+1.8% · S&P 500 +0.6%
Boundless Bio closed at its highest level of the year, 138.1% above where the year started.
+3.4% · S&P 500 +0.4%
Where it ended: a close of $2.46 on Nov 11, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-0.56).
Nothing in the past 12 months.
All BOLD analyst actionsNothing in the past 12 months.
All BOLD dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BOLD and SPY from Benzinga historical bars. Not investment advice.
